logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
BFRI
Biofrontera Inc.
1.27
1 x 1.24
1 x 1.36
bid
ask
+
0.02
1.60%
150 @ 04:00 PM
1.26 -0.01 (0.71%)
Ytd122.81%
1y33.68%
1.23
day range
1.27
0.57
52 week range
1.27
Open1.27Prev Close1.25Low1.23High1.27Mkt Cap16.26M
Vol246.52KAvg Vol322.78KEPS-1.07P/E-1.19Forward P/E-1.17
Beta0.51Short Ratio0.08Inst. Own20.68%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg1.01200-d Avg0.941yr Est11.50

BFRI News

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
globenewswire.com
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or t

Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript

Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript

Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
globenewswire.com
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 20

WOBURN, Mass. , May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) ("Biofrontera" or t

This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
benzinga.com
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se

Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
zacks.com
Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates

Biofrontera Inc. (BFRI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
globenewswire.com
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

Woburn, MA, May 14, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the "Company"), a biop

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
globenewswire.com
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosi

Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
globenewswire.com
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14

WOBURN, Mass. , May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) ("Biofrontera" or t

Biofrontera Q4 Earnings Call Highlights
defenseworld.net
Biofrontera Q4 Earnings Call Highlights

Biofrontera (NASDAQ: BFRI) reported record revenue for both the fourth quarter and full year 2025, d

Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript
seekingalpha.com
Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript

Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript

Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
globenewswire.com
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a B

Conference call will be held today, Thursday, March 19 at 10:00 am ET Woburn, MA, March 19, 2026 (GL

Earnings Scheduled For March 19, 2026
benzinga.com
Earnings Scheduled For March 19, 2026

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
globenewswire.com
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference

WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why
zacks.com
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism abou

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
globenewswire.com
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photody

• Phase 2b study demonstrated greater reductions in inflammatory acne lesions with Ameluz ® PDT vers

U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma's Patent 11,697,028 To Be Unpatentable
globenewswire.com
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma's Paten

WOBURN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutica

Contrasting Biofrontera (NASDAQ:BFRI) & RenovaCare (OTCMKTS:RCAR)
defenseworld.net
Contrasting Biofrontera (NASDAQ:BFRI) & RenovaCare (OTCMKTS:RCAR)

RenovaCare (OTCMKTS:RCAR - Get Free Report) and Biofrontera (NASDAQ: BFRI - Get Free Report) are bot

Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities
globenewswire.com
Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Ke

WOBURN, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma
globenewswire.com
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in

WOBURN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint
globenewswire.com
Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the

WOBURN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For August 13, 2025
benzinga.com
Earnings Scheduled For November 13, 2024
benzinga.com
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 429 stocks made new 52-week lows.